AXB

60.5

+0.83%↑

JPM

291.11

-1.03%↓

BAC

45.52

-0.68%↓

WFC

77.92

+0.5%↑

MS

140.6

-0.51%↓

AXB

60.5

+0.83%↑

JPM

291.11

-1.03%↓

BAC

45.52

-0.68%↓

WFC

77.92

+0.5%↑

MS

140.6

-0.51%↓

AXB

60.5

+0.83%↑

JPM

291.11

-1.03%↓

BAC

45.52

-0.68%↓

WFC

77.92

+0.5%↑

MS

140.6

-0.51%↓

AXB

60.5

+0.83%↑

JPM

291.11

-1.03%↓

BAC

45.52

-0.68%↓

WFC

77.92

+0.5%↑

MS

140.6

-0.51%↓

AXB

60.5

+0.83%↑

JPM

291.11

-1.03%↓

BAC

45.52

-0.68%↓

WFC

77.92

+0.5%↑

MS

140.6

-0.51%↓

Primerica Inc

Затворен

СекторФинансови

264.35 -0.14

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

262.21

Максимум

267.25

Ключови измерители

By Trading Economics

Приходи

2M

169M

Продажби

17M

805M

P/E

Средно за сектора

12.182

25.916

Дивидентна доходност

1.46

Марж на печалбата

21.004

Служители

2,289

EBITDA

-2.8M

226M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+18.43% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.46%

3.70%

Следващи печалби

6.08.2025 г.

Следваща дата на дивидент

11.09.2025 г.

Следваща дата на екс-дивидент

20.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.1B

8.7B

Предишно отваряне

264.49

Предишно затваряне

264.35

Настроения в новините

By Acuity

50%

50%

199 / 536 Класиране в Finance

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Primerica Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

4.08.2025 г., 21:42 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4.08.2025 г., 21:21 ч. UTC

Печалби
Значими двигатели на пазара

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4.08.2025 г., 20:45 ч. UTC

Печалби

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4.08.2025 г., 19:15 ч. UTC

Значими двигатели на пазара

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4.08.2025 г., 23:41 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

4.08.2025 г., 23:41 ч. UTC

Пазарно говорене

Nikkei May Rise on Fed Stimulus Hopes

4.08.2025 г., 23:28 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

4.08.2025 г., 23:28 ч. UTC

Пазарно говорене

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4.08.2025 г., 21:30 ч. UTC

Печалби

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4.08.2025 г., 21:21 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4.08.2025 г., 21:18 ч. UTC

Печалби

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4.08.2025 г., 20:25 ч. UTC

Пазарно говорене

India Hits Back Over Russian Oil Purchases -- Market Talk

4.08.2025 г., 20:25 ч. UTC

Печалби

Transocean 2Q Loss $938M >RIG

4.08.2025 г., 20:25 ч. UTC

Печалби

Transocean 2Q Loss/Shr $1.06 >RIG

4.08.2025 г., 20:18 ч. UTC

Печалби

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4.08.2025 г., 20:15 ч. UTC

Печалби

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4.08.2025 г., 20:14 ч. UTC

Печалби

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4.08.2025 г., 20:14 ч. UTC

Печалби

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4.08.2025 г., 20:14 ч. UTC

Печалби

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4.08.2025 г., 20:13 ч. UTC

Печалби

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4.08.2025 г., 20:09 ч. UTC

Печалби

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4.08.2025 г., 20:06 ч. UTC

Печалби

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4.08.2025 г., 20:01 ч. UTC

Печалби

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4.08.2025 г., 19:41 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Settle Lower -- Market Talk

4.08.2025 г., 19:28 ч. UTC

Пазарно говорене

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4.08.2025 г., 19:07 ч. UTC

Пазарно говорене

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4.08.2025 г., 18:27 ч. UTC

Пазарно говорене

Gold Climbs on Rate Cut Speculation -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Primerica Inc Прогноза

Ценова цел

By TipRanks

18.43% нагоре

12-месечна прогноза

Среден 307.29 USD  18.43%

Висок 340 USD

Нисък 290 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Primerica Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

8 ratings

2

Купи

6

Задържане

0

Продай

Техническа оценка

By Trading Central

261.57 / N/AПодкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

199 / 536 Класиране в Финансови

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Среден

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Primerica Inc

Primerica, Inc., together with its subsidiaries, provides financial products and services to middle-income households in the United States and Canada. The company operates in four segments: Term Life Insurance; Investment and Savings Products; Senior Health; and Corporate and Other Distributed Products. The Term Life Insurance segment underwrites individual term life insurance products. The Investment and Savings Products segment provides mutual funds and various retirement plans, managed investments, variable and fixed annuities, and fixed indexed annuities. The Senior Health segment offers segregated funds; and medicare advantage and supplement plans. The Corporate and Other Distributed Products segment provides mortgage loans; prepaid legal services that assist subscribers with legal matters, such as drafting wills, living wills and powers of attorney, trial defense, and motor vehicle-related matters; ID theft defense services; auto and homeowners' insurance; home automation solutions; and insurance products, including supplemental and accidental death, and disability insurance. It distributes and sells its products through licensed sales representatives. Primerica, Inc. was founded in 1927 and is headquartered in Duluth, Georgia.